Sugi Predict

Sugi Predict / Compounds / SCHEMBL5606923

SCHEMBL5606923

SCHEMBL5606923

COCCCCNC(=O)Nc1nc(C)c(C(=O)Nc2c(C)cc(C)cc2C)s1.Cc1cc(C)c(NC(=O)c2sc(NC(=O)NCCC(C)(C)C)nc2C)c(C)c1

nearest known ligand 0.69

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ LCK P06239 18/20 0.69

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL774363 0.93 LCK (0.79) LCK
SCHEMBL771813 0.92 LCK (0.75) LCK
SCHEMBL772633 0.86 LCK (0.77) LCK
SCHEMBL774081 0.83 LCK (0.92) LCK
SCHEMBL774822 0.83 LCK (0.92) LCK
SCHEMBL773918 0.82 LCK (1.00) LCK
SCHEMBL772499 0.81 LCK (0.85) LCK
SCHEMBL773854 0.80 LCK (0.87) LCK
SCHEMBL772787 0.78 LCK (0.79) LCK
SCHEMBL773742 0.78 LCK (0.75) LCK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1758564-A2 SYNERGISTIC METHODS AND COMPOSITIONS FOR TREATING CANCER Brystol-Myers Squibb Company (US) 2007-03-07 — — EP claimed
WO-2005094376-A2 SYNERGISTIC METHODS AND COMPOSITIONS FOR TREATING CANCER BRISTOL-MYERS SQUIBB COMPANY (US) 2005-10-13 — — WO claimed
EP-1758564-A2 SYNERGISTIC METHODS AND COMPOSITIONS FOR TREATING CANCER Brystol-Myers Squibb Company (US) 2007-03-07 — — EP disclosed
WO-2005094376-A2 SYNERGISTIC METHODS AND COMPOSITIONS FOR TREATING CANCER BRISTOL-MYERS SQUIBB COMPANY (US) 2005-10-13 — — WO disclosed